Importantly, our findings indicate that MT enhances NSC differentiation into functional DA neurons by upregulating MFN2 expression, underscoring the potential application of targeting the MT-MFN2 signaling axis for generating functional DA neurons in vitro, which holds significant promise for PD therapy. The gene discussed is MFN2; the disease is Parkinson disease.